Enter inventor name

Hassan Jomaa

USPTO Granted Patents = 9 (Patent Applications = 4)

Average Co-Inventor Count = 1.6

ph-index = 5

Forward Citations = 57(Granted Patents)

Company Filing History:

4. 1 out of 832,843

Other

patents

Years Active: 2003-2011

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7875279 - Inactivation of genes of the MEP pathway (2011-01-25),

2. 7871992 - Organophosphorous compounds for the activation of gamma/delta T cells (2011-01-18),

3. 7638505 - Organophosphoric derivatives useful as anti-parasitic agents (2009-12-29),

4. 7399756 - Organo-phosphorous compounds for activating gamma/delta T cells (2008-07-15),

5. 6812224 - Phosphorous organic compounds and their use (2004-11-02),

6. 6753324 - Phosphorous organic compounds and their use (2004-06-22),

7. 6696427 - Use of bisphosphonates for the prevention and treatment of infectious processes (2004-02-24),

8. 6638957 - Use of compounds with a nitrogen-oxygen heterocycle (2003-10-28),

9. 6534489 - Organophosphorus compounds and the use thereof (2003-03-18),

Sure, I understand you are looking for an article about inventor Hassan Jomaa's dedication to innovation. Let me provide you with the article structured as you requested:

Title: Innovator Spotlight: Hassan Jomaa - Pioneering Inventor in the World of Technology

Introduction:

Hassan Jomaa, a visionary inventor based in Giessen, Germany, has earned renown for his unwavering commitment to innovation and his relentless pursuit of excellence. With a career dedicated to pushing the boundaries of what is possible in the realm of technology, Jomaa continues to inspire future generations of inventors.

Latest Patents:

Jomaa's impressive portfolio includes a total of 9 patents, showcasing his expertise and creativity in bridging scientific discovery with practical applications. Among his latest patents are groundbreaking inventions such as "Inactivation of genes of the MEP pathway" and "Organophosphorous compounds for the activation of gamma/delta T cells."

Career Highlights:

Having made significant contributions to the field of biotechnology, Jomaa has been instrumental in developing methods for enhancing the production of intermediates in the mevalonate-independent pathway for isoprenoid biosynthesis. His innovative approaches have paved the way for advancements in enzyme activity testing and the production of medicaments.

Collaborations:

Throughout his illustrious career, Jomaa has collaborated with esteemed professionals in the industry, including Boran Altincicek and Jochen Wiesner. Together, they have combined their expertise to explore new frontiers in biopharmaceuticals and molecular biology, driving forward progress in cutting-edge research and development initiatives.

Conclusion:

In conclusion, Hassan Jomaa's dedication to innovation and his groundbreaking inventions have left an indelible mark on the world of technology. His pioneering spirit and unwavering commitment to excellence serve as a testament to the transformative power of visionary thinking and collaboration in shaping the future of scientific discovery. Jomaa's legacy continues to inspire and motivate aspiring inventors to reach new heights in their pursuit of groundbreaking innovations.

If you would like to know more about other innovative inventors or patent-related topics, feel free to ask!

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com